Unicycive Therapeutics, Inc. Quarterly Preferred Stock, Shares Authorized from Q4 2020 to Q1 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Summary
Unicycive Therapeutics, Inc. quarterly Preferred Stock, Shares Authorized history and growth rate from Q4 2020 to Q1 2024.
  • Unicycive Therapeutics, Inc. Preferred Stock, Shares Authorized for the quarter ending March 31, 2024 was 9.9M shares, a 32708% increase year-over-year.
Preferred Stock, Shares Authorized, Quarterly (shares)
Preferred Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 9.9M +9.87M +32708% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 9.93M -73.8K -0.74% Dec 31, 2023 10-Q 2024-05-13
Q3 2023 9.93M -73.8K -0.74% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 9.97M -30.2K -0.3% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 30.2K -9.97M -99.7% Mar 31, 2023 10-Q 2023-05-16
Q4 2022 10M 0 0% Dec 31, 2022 10-K 2024-03-28
Q3 2022 10M 0 0% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 10M 0 0% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 10M Mar 31, 2022 10-Q 2022-05-12
Q4 2021 10M 0 0% Dec 31, 2021 10-K 2023-03-31
Q3 2021 10M Sep 30, 2021 10-Q 2021-11-12
Q2 2021 10M Jun 30, 2021 10-Q 2021-08-16
Q4 2020 10M Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.